Semaglutide
Semaglutide is a pharmaceutical drug with 330 clinical trials. Currently 83 active trials ongoing. Historical success rate of 99.0%.
Success Metrics
Based on 195 completed trials
Phase Distribution
Phase Distribution
70
Early Stage
61
Mid Stage
139
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
95.6%
195 of 204 finished
4.4%
9 ended early
83
trials recruiting
330
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
A Study of CS060380 Tablets in Patients With MASH and Obesity
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
Clinical Trials (330)
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
A Study of CS060380 Tablets in Patients With MASH and Obesity
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
A Study of BGM0504 in Early T2DM With Obesity
A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes
Semaglutide Therapy for Alcohol Reduction (STAR)
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
Sit Less, Interact and Move More (SLIMM) 2 Study
COMMETS- Combination MCI Metabolic Syndrome
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 330